@prefix jvr: <http://data.loterre.fr/ark:/67375/JVR> .
@prefix skos: <http://www.w3.org/2004/02/skos/core#> .
@prefix mesh: <http://id.nlm.nih.gov/mesh/vocab#> .
@prefix dc: <http://purl.org/dc/terms/> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .
@prefix owl: <http://www.w3.org/2002/07/owl#> .

jvr:-L6C0XPHT-4
  skos:prefLabel "métabolisme (Qualificatif)"@fr, "metabolism (Qualifier)"@en ;
  a mesh:Qualifier, skos:Concept .

jvr:-G7KXQWSR-5
  skos:prefLabel "biosynthèse (Qualificatif)"@fr, "biosynthesis (Qualifier)"@en ;
  a mesh:Qualifier, skos:Concept .

jvr:-Z9TSGBXH-4
  skos:prefLabel "génétique (Qualificatif)"@fr, "genetics (Qualifier)"@en ;
  a mesh:Qualifier, skos:Concept .

jvr:-Q3979798-W
  skos:prefLabel "analysis (Qualifier)"@en, "analyse (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-N000KL24-M
  skos:prefLabel "Phencyclidine"@fr, "Phencyclidine"@en ;
  a mesh:Descriptor, skos:Concept ;
  skos:related jvr:-X9JNSGB2-G .

jvr:-H7K65Q8S-Z
  skos:prefLabel "radiation effects (Qualifier)"@en, "effets des radiations (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-TJHVZCRZ-0
  skos:prefLabel "administration et posologie (Qualificatif)"@fr, "administration & dosage (Qualifier)"@en ;
  a mesh:Qualifier, skos:Concept .

jvr:-FWD2BGQ0-9
  skos:prefLabel "usage thérapeutique (Qualificatif)"@fr, "therapeutic use (Qualifier)"@en ;
  a mesh:Qualifier, skos:Concept .

jvr:-R0ZCQ8X6-J
  skos:prefLabel "agonistes (Qualificatif)"@fr, "agonists (Qualifier)"@en ;
  a mesh:Qualifier, skos:Concept .

jvr:-RNB574S9-Q
  skos:prefLabel "Receptors, Drug"@en, "Récepteurs des médicaments"@fr ;
  a mesh:Descriptor, skos:Concept ;
  skos:narrower jvr:-X9JNSGB2-G .

jvr:-S0CS1X5R-5
  skos:prefLabel "immunology (Qualifier)"@en, "immunologie (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-M63HSDM7-1
  skos:prefLabel "antagonists & inhibitors (Qualifier)"@en, "antagonistes et inhibiteurs (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-T2TS0S41-N
  skos:prefLabel "ultrastructure (Qualifier)"@en, "ultrastructure (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-HQRFT0C6-B
  skos:prefLabel "isolement et purification (Qualificatif)"@fr, "isolation & purification (Qualifier)"@en ;
  a mesh:Qualifier, skos:Concept .

jvr:-W6SQV79N-S
  skos:prefLabel "classification (Qualifier)"@en, "classification (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr: a skos:ConceptScheme .
jvr:-SBNWSM1T-R
  skos:prefLabel "history (Qualifier)"@en, "histoire (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-CJXMKG5Q-F
  skos:prefLabel "deficiency (Qualifier)"@en, "déficit (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-D0F21513-5
  skos:prefLabel "chemistry (Qualifier)"@en, "composition chimique (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-NHL3D2X0-S
  skos:prefLabel "sang (Qualificatif)"@fr, "blood (Qualifier)"@en ;
  a mesh:Qualifier, skos:Concept .

jvr:-X9JNSGB2-G
  mesh:allowableQualifier jvr:-G7KXQWSR-5, jvr:-WZF2ZR3L-B, jvr:-N2WP45CN-V, jvr:-NHL3D2X0-S, jvr:-W6SQV79N-S, jvr:-T2TS0S41-N, jvr:-H7K65Q8S-Z, jvr:-CJXMKG5Q-F, jvr:-L6C0XPHT-4, jvr:-SBNWSM1T-R, jvr:-HQRFT0C6-B, jvr:-Q3979798-W, jvr:-FWD2BGQ0-9, jvr:-D0F21513-5, jvr:-R0ZCQ8X6-J, jvr:-S0CS1X5R-5, jvr:-Z9TSGBXH-4, jvr:-M63HSDM7-1, jvr:-TJHVZCRZ-0 ;
  dc:created "1992-05-22"^^xsd:date ;
  a skos:Concept, mesh:Descriptor ;
  skos:altLabel "Récepteurs à la phencyclidine"@fr, "Phencyclidine Receptors"@en, "Récepteurs de la PCP"@fr, "PCP Receptor"@en, "PCP Receptors"@en, "Phencylidine Receptor"@en, "Receptors, PCP"@en, "Récepteurs à la PCP"@fr ;
  skos:inScheme jvr: ;
  skos:prefLabel "Receptors, Phencyclidine"@en, "Récepteurs de la phencyclidine"@fr ;
  dc:modified "1997-06-20"^^xsd:date ;
  skos:broader jvr:-RNB574S9-Q ;
  dc:established "1993-01-01"^^xsd:date ;
  skos:related jvr:-N000KL24-M ;
  owl:sameAs <http://id.nlm.nih.gov/mesh/D017478> ;
  skos:definition "Specific sites or molecular structures on cell membranes or in cells with which phencyclidine reacts or to which it binds to elicit the specific response of the cell to phencyclidine. Studies have demonstrated the presence of multiple receptor sites for PCP. These are the PCP/sigma site, which binds both PCP and psychotomimetic opiates but not certain antipsychotics, and the PCP site, which selectively binds PCP analogs."@en .

jvr:-N2WP45CN-V
  skos:prefLabel "drug effects (Qualifier)"@en, "effets des médicaments et des substances chimiques (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-WZF2ZR3L-B
  skos:prefLabel "physiology (Qualifier)"@en, "physiologie (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .